Cure Research for Chronic Hepatitis C
Cure Research list for Chronic Hepatitis C:
The list of research areas and treatments under analysis mentioned
in various sources for Chronic Hepatitis C
includes:
Latest Treatments for Chronic Hepatitis C
Some of the more recent treatments for Chronic Hepatitis C include:
Treatments for Chronic Hepatitis C
Treatments to consider for Chronic Hepatitis C may include:
Cure Research discussion for Chronic Hepatitis C:
Basic Research
A major focus of hepatitis C research is developing a
tissue culture system that will enable researchers to study HCV outside the
human body. Animal models and molecular approaches to the study of HCV are also
important. Understanding how the virus replicates and how it injures cells would
be helpful in developing a means of controlling the virus and in screening for
new drugs that would block it.
Diagnostic Tests
More sensitive and less expensive assays for measuring
HCV RNA and antigens in the blood and liver are needed. Although current tests
for anti-HCV are quite sensitive, a small percentage of patients with hepatitis
C test negative for anti-HCV (false-negative reaction), and a percentage of
patients who test positive are not infected (false-positive reaction). Also,
there are patients who have resolved the infection but still test positive for
anti-HCV. Convenient tests to measure HCV in serum and to detect HCV antigens in
liver tissue would be helpful.
New Treatments
Most critical for the future is the development of new
antiviral agents for hepatitis C. Most interesting will be specific inhibitors
of HCV-derived enzymes such as protease, helicase, and polymerase inhibitors.
Drugs that inhibit other steps in HCV replication may also be helpful in
treating this disease, by blocking production of HCV antigens from the RNA (IRES
inhibitors), preventing the normal processing of HCV proteins (inhibitors of
glycosylation), or blocking entry of HCV into cells (by blocking its receptor).
Nonspecific cytoprotective agents might also be helpful for hepatitis C by
blocking the cell injury caused by the virus infection. Further, molecular
approaches to treating hepatitis C are worthy of investigation; these consist of
using ribozymes, which are enzymes that break down specific viral RNA molecules,
and antisense oligonucleotides, which are small complementary segments of DNA
that bind to viral RNA and inhibit viral replication. All of these approaches
remain experimental and have not been applied to humans. The serious nature and
the frequency of hepatitis C in the population make the search for new therapies
of prime importance.
Prevention
At present, the only means of preventing new cases of
hepatitis C are to screen the blood supply, encourage health professionals to
take precautions when handling blood and body fluids, and inform people about
high-risk behaviors. Programs to promote needle exchange offer some hope of
decreasing the spread of hepatitis C among injection drug users. Vaccines and
immunoglobulin products do not exist for hepatitis C, and development seems
unlikely in the near future because these products would require antibodies to
all the genotypes and variants of hepatitis C. Nevertheless, advances in
immunology and innovative approaches to immunization make it likely that some
form of vaccine for hepatitis C will eventually be developed.
(Source: excerpt from
Chronic Hepatitis C Current Disease Management: NIDDK)
Medical research for Chronic Hepatitis C: medical news summaries:
The following medical news items
are relevant to medical research for Chronic Hepatitis C:
Chronic Hepatitis C Treatment: Book Excerpts
Clinical Trials for Chronic Hepatitis C
Some of the clinical trials for Chronic Hepatitis C include:
Evidence Based Medicine Research for Chronic Hepatitis C
Medical research papers related to Chronic Hepatitis C include:
Click here to find more evidence-based articles on the TRIP Database
Hepatitis C is called a silent epidemic because many people are unaware they carry this virus of the liver. But experts say hepatitis C is a public...
Liver problems may be difficult to avoid when taking HIV medicines. But most problems are relatively mild and do not prevent people with HIV from...
Many people with viral hepatitis don't know they are infected. Listen as experts discuss who should be tested and review the causes, prevention...
Sexual contact can sometimes result in problems. An unwanted pregnancy or sexually transmitted diseases may be some of those consequences. But by...
See full list of 4 related videos
» Next page: Deaths from Chronic Hepatitis C
Rate This Website
What do you think about the features of this website?
Take our user survey and have your say:
Website User Survey
Medical Tools & Articles:
Next articles:
Tools & Services:
Medical Articles:
Forums & Message Boards
- Ask or answer a question at the Boards: